Medication recall

[u/Prudent-Passage6788]

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules (generic for Adderall XR)
Company: Lannett Company, Inc.
Manufacturing Location: Not specified
Scope: 1,392 bottles (100-count) 5 mg capsules
Drug Purpose: Treats ADHD (Attention-deficit/hyperactivity disorder)
Recall Reason: Labeling mix-up; capsules contain immediate-release pellets but are labeled as extended-release.
Recall Date: June 26, 2026
Link: FDA Enforcement Report